Fierce Pharma

OCTOBER 12, 2023

An apparent win for Novo Nordisk’s GLP-1 blockbuster Ozempic in chronic kidney disease (CKD) could herald a shift in how the condition has been treated for decades. | Based on the inclusion criteria for Novo Nordisk’s chronic kidney disease trial, dialysis bigwig DaVita believes there may only be “limited application” of the study’s findings to the overall CKD population.

267

267

Dominic Tyer

OCTOBER 12, 2023

There’s a digital drop-off for the pharma content that HCPs in Europe’s five biggest markets say they need the most from the industry.

Pharma 130

Pharma Marketing 130

Fierce Pharma

OCTOBER 12, 2023

Even as Teva Pharmaceuticals’ Icelandic counterpart Alvotech works to get its Reykjavik manufacturing facility back up to snuff, lingering problems at the plant—which derailed approval of the partn | The FDA shot down Alvotech and Teva's biosimilar candidate to Johnson & Johnson's Stelara over “certain deficiencies” uncovered by the FDA during a reinspection of the company's factory in Iceland earlier this year.

FDA 262

FDA Manufacturing Pharmaceutical 262

MedCity News

OCTOBER 12, 2023

European Union regulators ordered Illumina to divest Grail. Illumina is appealing antitrust findings in Europe and the U.S., but the DNA sequencing giant revealed that divesting all or part of Grail is an option even if it wins both legal challenges.

Sales 109

Sales Competition Biopharma 109

Advertisement

Distribution

Fierce Pharma

OCTOBER 12, 2023

Pfizer is expanding the reach of its BRAF-MEK combo as the pharma giant looks to further build up its oncology presence. | Pfizer is expanding the reach of its BRAF-MEK combo as the pharma giant looks to further build up its oncology presence.

Pharma 221

Pharma FDA 221

MedCity News

OCTOBER 12, 2023

At HLTH, Bessemer investors Sofia Guerra and Steve Kraus detailed four predictions about where they think the digital health world is headed in 2024. One of these was that “services-as-software” will emerge as a new category of healthcare AI. Another was that some healthcare technology vendors will have to rethink their distribution models and rely on indirect monetization strategies.

Distribution 110

Distribution Healthcare Healthcare 110

MedCity News

OCTOBER 12, 2023

Noom is now offering Noom Med to employers. The program is intended for patients who need more clinical support in their weight loss journey. It offers access to a clinician and medications, including GLP-1s.

Management 108

Management Medical Patients 108

Fierce Pharma

OCTOBER 12, 2023

GSK has tapped Chongqing Zhifei to distribute Shingrix in China. BioNTech in-licensed a HER3 antibody-drug conjugate from Chinese company MediLink Therapeutics. | GSK has tapped Chongqing Zhifei to distribute Shingrix in China. BioNTech in-licensed a HER3 antibody-drug conjugate from Chinese company MediLink Therapeutics. The FDA rejected Biocon's proposed biosimilar version of Novo Nordisk's NovoLog—again.

Distribution 197

Distribution Pharma FDA 197

MedCity News

OCTOBER 12, 2023

Walmart’s relationship with Included Health dates back to 2016 when its previous incarnation – Doctor on Demand – began providing virtual urgent care services to Walmart employees in three states. Nearly eight years later, the San Francisco company continues to be the only partner charged with delivering virtual primary care to almost 1 million people in 49 states.

Doctors 107

Doctors 107

Fierce Pharma

OCTOBER 12, 2023

In this discussion, Steve Carickhoff, President of BioPharm Communications, a company specializing in third-party, omnichannel promotion, discusses some of the challenges and opportunities facing p | As pharma evolves it’s marketing approach should be more omnichannel focused, there is more to the equation than just how to use data. Depth of content is an equally important variable in the mix.

Marketing 130

Marketing Specialization Pharma 130

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

MedCity News

OCTOBER 12, 2023

BioNTech gains rights to a MediLink Therapeutics antibody drug conjugate that targets tumors expressing the HER3 protein. The deal comes six months after the German company entered the ADC field by acquiring rights to two therapeutic candidates from DualityBio.

Biopharma 105

Biopharma Pharma 105

PharmExec

OCTOBER 12, 2023

A discussion of the impact the new FDA SaMD guidance, identifying the differences between companion apps and SaMD, and what to expect from this combination in the future.

FDA 105

FDA 105

European Pharmaceutical Review

OCTOBER 12, 2023

A new scheme from the Medicines and Healthcare products Regulatory Agency (MHRA) is set to cut the approval time for the lowest-risk clinical trials in the UK by over half. The new Notification Scheme is based on that outlined in the MHRA’s clinical trials consultation, which was endorsed by 74 percent of those who responded. It forms a significant part of the regulator’s overhaul of the clinical trials regulation announced in March 2023, which aims to make the UK a prime location for con

Ethics 94

Ethics Safety Medicine Consulting 94

PharmaTimes

OCTOBER 12, 2023

The financing will support the biotech’s clinical study of people with AD as a lead programme - News - PharmaTimes

Leads 111

Leads 111

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmaTech

OCTOBER 12, 2023

The 65,000-square-foot facility is designed with the capacity and capability to help scale the next generation of CGTs for human trials and beyond.

Pharma 98

Pharma 98

MedCity News

OCTOBER 12, 2023

In this episode, we discuss SCAN Health Plan’s recent launch of SCAN Inspired, a Medicare Advantage plan designed for women.

101

101

European Pharmaceutical Review

OCTOBER 12, 2023

Strong demand for small molecules as treatment for non-small cell lung cancer (NSCLC) in the eight major markets means that the small molecule treatment market for the disease is expected to reach over $15 billion by 2029. This represents approximately 40 percent of the total NSCLC market, stated GlobalData. Sales for AstraZeneca’s Tagrisso are anticipated to exceed $7 billion and hold a 48 percent share of the market of small molecules in lung cancer treatment by 2029, according to data and ana

Marketing 84

Marketing Sales Medicine FDA 84

Pharmaceutical Technology

OCTOBER 12, 2023

IMIDomics has entered into a licence and partnership agreement with the University of Barcelona (UB) to advance treatments for IMIDs.

97

97

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety

PharmaTech

OCTOBER 12, 2023

The companies will co-promote GSK’s shingles vaccine, Shingrix, to healthcare professionals and points of vaccination in China.

Healthcare 98

Healthcare Healthcare 98

PharmExec

OCTOBER 12, 2023

A look at the intersection of rigorous compliance and ethical behavior: independent, charitable patient assistance foundations.

Safety 98

Safety Ethics Patients 98

PharmaTimes

OCTOBER 12, 2023

The service will benefit major research and industry projects across the UK - News - PharmaTimes

Leads 104

Leads 104

Clarify Health

OCTOBER 12, 2023

The concept of value-based care (VBC) isn’t new — but the industry’s journey to achieve it is far from over. After two decades, healthcare is still working to find a better way to reward clinicians for the quality and efficiency of the care they provide rather than for the volume of patients treated. Payers are uniquely positioned to drive value-based care Healthcare payers can play a significant role in helping providers deliver better patient outcomes as they have a unique combin

Healthcare Provider 59

Healthcare Provider Insurance Healthcare Healthcare 59

Advertisement

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

Specialization

PM360

OCTOBER 12, 2023

The Creative Floor Awards have created a brand new working from home candle collection that will be an additional revenue generator for their Talent & Diversity Fund. The platform has collaborated with the world’s best mixologists and yogis to create four exclusive scents to help people thrive with working from home. Only 100 candles per scent have been created.

Ethics 59

Ethics Leads Healthcare Healthcare 59

Clarivate

OCTOBER 12, 2023

In a world driven by rapid advancements in artificial intelligence (AI), the landscape of intellectual property (IP) law and practice is poised for a transformative shift. Generative AI has entered the mainstream with a ripple effect on the industry. Our latest report, Redefining AI: How IP Practice Meets the Coming Wave, puts the perception of AI front and center to understand what’s next for the IP.

Ethics 59

Ethics 59

pharmaphorum

OCTOBER 12, 2023

Incyte’s oral vitiligo drug heading for phase 3 Phil.

94

94

PharmaTech

OCTOBER 12, 2023

Do you face challenges when it comes to the particle quality in your granulation process? In order to produce granules with the desired properties, scale-up is crucial, in addition to looking at the process parameters. After all, the path of a drug from the laboratory to production holds many a surprise. Especially in the case of particles for inhalers, the mixing process plays a decisive role.

52

52

Advertisement

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

Leads

Referral MD

OCTOBER 12, 2023

Photo by Luis Melendez on Unsplash Improving patient engagement has recently become a top priority in the healthcare sector. This shift has been driven by the realization that involving patients in their care can lead to better health outcomes and increased satisfaction. One major factor that promotes patient engagement is care coordination. This blog post will discuss how care coordination enhances patient engagement and its impact on healthcare.

Patients 52

Patients Healthcare Provider Healthcare Healthcare 52

PharmaTech

OCTOBER 12, 2023

Humberto Vega, PhD, Executive Director, Bristol Myers Squibb, discusses the journey from clinical to commercial cell therapies as a part of his session, "Successfully Navigating Global Cell Therapy Requirements.

52

52

PM360

OCTOBER 12, 2023

OptimizeRx Corp., the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced it has signed an agreement to acquire Scottsdale, Arizona-based Healthy Offers, Inc., dba Medicx Health , a leading healthcare consumer-focused omnichannel marketing and analytics company.

Healthcare 52

Healthcare Healthcare Marketing Leads 52

Copyright Clearance Center

OCTOBER 12, 2023

CCC added new data import capabilities and AI-enabled affiliation matching in its OA Agreement Intelligence modeling and analytics tool that provides publishers with a 360-degree view of disambiguated publication data to build accurate, transparent institutional offers regarding OA.

52

52

Advertisement

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

Management